NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Cota Inc., a real-world data and analytics company bridging precision medicine to population health, today announced its chief medical officer, Andrew Norden, M.D., will speak at the HealthXL Global Gathering in Pittsburgh, Pennsylvania on February 8, 2018. The event, which will take place at the National Robotics Engineering Center, showcases leaders and innovators from the world's most disruptive technology companies in healthcare.
Norden will speak under the precision medicine track, "Does Precision Medicine Require Precise Data?" During his portion of the presentation, Dr. Norden will share how Cota is accelerating the path to precision medicine and oncology value-based care with providers across the country. Case studies will focus on Cota's collaboration with leading providers like Hackensack Meridian Health and Baptist Health South Florida.
Cota's end-to-end provider solutions are comprised of Real-World Evidence (RWE) analytics, decision support and value-based tracking. Leveraging the patented Cota Nodal Address™ (CNA), a precision patient classification system, and Cota Real-World Evidence (RWE), the industry's leading collection of oncology patient data, Cota's solutions improve quality and outcome in cancer care, increase oncology margins in fee-for-service and value-based arrangements and assist practices looking to transition to value-based care.
For those interested in attending Dr. Norden's presentation, please refer to the following information:
- What: "Does Precision Medicine Require Precise Data?" session
- Who: Dr. Andrew Norden, chief medical officer of Cota
- When: Thursday, February 8
- Where: National Robotics Engineering Center, Pittsburgh, PA
For more information or to schedule a meeting with Cota at the event, please reach out to Cota via firstname.lastname@example.org.
Cota is a real-world data and analytics company that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.
Cota's technology enriches medical records to create research-grade data and joins it with a suite of analysis, visualization and management tools. This enables providers, payers and life science companies to analyze, report on and research outcomes, costs, treatments and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and medicine to improve the lives of patients everywhere. For more information, go to www.cotahealthcare.com